Ann: Alcidion Quarterly Results and Investor Webcast Notification, page-34

Revised questions based on comments. Welcome more feedback to add/delete/change questions

1 - Does Alcidion see India as a target area and if so whatis the Total Addressable Market to which Alcidion could penetrate? If yes howcan ALC contribute and benefit. Adoption in a new region would be beneficialbut would come with technical issues, would the system still be used in Englishor would the entire system need to be converted to a different dialect?

2 - The NZ DHBs are being consolidated into largerhealth boards this comes with risks to existing contracts and also potentialbenefits to potentially larger contracts. Will the larger DHBs benefit ALC?

3 - There has been some very informative Webinarsdirected at clinicians in the last few months which have showcased theproducts, much of this information has not been seen by current shareholders orpotential investors. As ALC has a very health cash balance would the companyconsider engaging a professional digital marketing company to produce astrategy and the content? This material is constantly online and available notonly to investors but to potential clients and would form a valuable showcaseof the product suite. I acknowledge some videos have been produced but feelthey do not reflect the standard for a 150mil Mcap company.

4 - Has the company provide any corporateroadshows to institutional investors in the financial year? Note - the abovemarketing would make this much easier to undertake and sell the company)

5 - As the company moves into breakeven andhopefully profitability in the near term does the company have any plans for itscash reserves.

6 - The issues facing the health system in Waleshas been well publicised has ALC made any inroads within their system.

7 - The Monklands replacement hospital planningappears to be well underway, to what extent will patientrack be deployed andwill there be further opportunities

8 - Are any case studies being undertaken toextract statistics which can help show the benefits using Miya?

9 – Can the company provide commentary on theprogress of the Silverlink acquisition.

• Can you update on the integration of the 2 systems
• Has the acquisition allowed for any tender opportunities previously not available and the size of these tenders.

10 - At East Lancs they have spent a considerable amount oftime and money to implement the Cerner system and have now selected Miya tooverlay this. Does the cerner system have the capability to do a similar roleto Miya and it is just they they prefer Miya over Cerner for that role or isCerner undertaking other systems only.

11 – With the EOFY in the UK being April and trusts havingrenewed budgets at this time there has been a lack of larger contracts withinthe NHS since then and in general over the last 12 months. With an increase in staffnumbers this hasn’t translated into larger contracts in the NHS. Can you providecommentary on this and the broader market conditions in the UK